182 related articles for article (PubMed ID: 16808100)
1. [Alternative hormone therapy in postmenopause].
Fistonić I; Canić T; Duić Z; Fistonić M; Ciglar S
Lijec Vjesn; 2006; 128(3-4):99-104. PubMed ID: 16808100
[TBL] [Abstract][Full Text] [Related]
2. Menopause and stroke and the effects of hormonal therapy.
Lobo RA
Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669
[TBL] [Abstract][Full Text] [Related]
3. Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy.
Skouby SO; Al-Azzawi F; Barlow D; Calaf-Alsina Erdogan Ertüngealp J; Gompel A; Graziottin A; Hudita D; Pines A; Rozenberg S; Samsioe G; Stevenson JC;
Maturitas; 2005 May; 51(1):8-14. PubMed ID: 15883103
[TBL] [Abstract][Full Text] [Related]
4. Prognostic features of menopausal and postmenopausal applicants for life insurance.
Schiefeling M
J Insur Med; 1996; 28(1):27-34. PubMed ID: 10172866
[TBL] [Abstract][Full Text] [Related]
5. WHI risks: any relevance to menopause management?
Burger HG
Maturitas; 2007 May; 57(1):6-10. PubMed ID: 17368974
[TBL] [Abstract][Full Text] [Related]
6. Climacteric medicine: European Menopause and Andropause Society (EMAS) statements on postmenopausal hormonal therapy.
Skouby SO; Barlow D; Samsioe G; Gompel A; Pines A; Al-Azzawi F; Graziottin A; Hudita D; Rozenberg S;
Maturitas; 2004 May; 48(1):19-25. PubMed ID: 15223104
[TBL] [Abstract][Full Text] [Related]
7. Patterns of hormone replacement therapy in a population-based cohort of postmenopausal German women. Changes after HERS II and WHI.
Clanget C; Hinke V; Lange S; Fricke R; Botko R; Pfeilschifter J
Exp Clin Endocrinol Diabetes; 2005 Oct; 113(9):529-33. PubMed ID: 16235155
[TBL] [Abstract][Full Text] [Related]
8. Implications of recent clinical trials of postmenopausal hormone therapy for management of cardiovascular disease.
Rossouw JE
Ann N Y Acad Sci; 2006 Nov; 1089():444-53. PubMed ID: 17261787
[TBL] [Abstract][Full Text] [Related]
9. Hormone therapy for younger postmenopausal women: how can we make sense out of the evidence?
Salpeter S
Climacteric; 2005 Dec; 8(4):307-10. PubMed ID: 16390764
[TBL] [Abstract][Full Text] [Related]
10. Hormone replacement therapy--is there a place for its use in neurology?
Vuković V; Lovrencić-Huzjan A; Solter VV; Dordević V; Demarin V
Coll Antropol; 2003 Jun; 27(1):413-24. PubMed ID: 12974172
[TBL] [Abstract][Full Text] [Related]
11. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.
Rosano GM; Maffei S; Andreassi MG; Vitale C; Vassalle C; Gambacciani M; Stramba-Badiale M; Mercuro G
J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):85-92. PubMed ID: 19145119
[TBL] [Abstract][Full Text] [Related]
12. Recent reversal of trends in hormone therapy use in a European population.
Morabia A; Costanza MC
Menopause; 2006; 13(1):111-5. PubMed ID: 16607106
[TBL] [Abstract][Full Text] [Related]
13. Hormone replacement therapy and cardiovascular disease revisited.
Stevenson JC
Menopause Int; 2009 Jun; 15(2):55-7. PubMed ID: 19465669
[TBL] [Abstract][Full Text] [Related]
14. Benefits and risks of long-term low-dose oral continuous combined hormone therapy.
van de Weijer PH; Mattsson LA; Ylikorkala O
Maturitas; 2007 Mar; 56(3):231-48. PubMed ID: 17034966
[TBL] [Abstract][Full Text] [Related]
15. Postmenopausal hormones and coronary artery disease: potential benefits and risks.
Lobo RA
Climacteric; 2007 Oct; 10 Suppl 2():21-6. PubMed ID: 17882668
[TBL] [Abstract][Full Text] [Related]
16. Are there second thoughts about the results of the WHI study?
Haimov-Kochman R; Hochner-Celnikier D
Acta Obstet Gynecol Scand; 2006; 85(4):387-93. PubMed ID: 16612699
[TBL] [Abstract][Full Text] [Related]
17. Hormone therapy in the WHI era.
Burger HG
Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):84-91. PubMed ID: 16638027
[TBL] [Abstract][Full Text] [Related]
18. The European Menopause Survey 2005: women's perceptions on the menopause and postmenopausal hormone therapy.
Genazzani AR; Schneider HP; Panay N; Nijland EA
Gynecol Endocrinol; 2006 Jul; 22(7):369-75. PubMed ID: 16864146
[TBL] [Abstract][Full Text] [Related]
19. Rationale for using raloxifene to prevent both osteoporosis and breast cancer in postmenopausal women.
Lee WL; Chao HT; Cheng MH; Wang PH
Maturitas; 2008 Jun; 60(2):92-107. PubMed ID: 18534794
[TBL] [Abstract][Full Text] [Related]
20. Impact of recent studies on attitudes and use of hormone therapy among Scandinavian gynaecologists.
Pedersen AT; Iversen OE; Løkkegaard E; Mattsson LA; Milsom I; Nilsen ST; Ottesen B; Moen MH
Acta Obstet Gynecol Scand; 2007; 86(12):1490-5. PubMed ID: 18027116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
